These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 27823960

  • 1. Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.
    Semenov AG, Tamm NN, Apple FS, Schulz KM, Love SA, Ler R, Feygina EE, Katrukha AG.
    Clin Biochem; 2017 Mar; 50(4-5):181-185. PubMed ID: 27823960
    [Abstract] [Full Text] [Related]

  • 2. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.
    Saenger AK, Rodriguez-Fraga O, Ler R, Ordonez-Llanos J, Jaffe AS, Goetze JP, Apple FS.
    Clin Chem; 2017 Jan; 63(1):351-358. PubMed ID: 28062628
    [Abstract] [Full Text] [Related]

  • 3. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.
    Prontera C, Zaninotto M, Giovannini S, Zucchelli GC, Pilo A, Sciacovelli L, Plebani M, Clerico A.
    Clin Chem Lab Med; 2009 Jan; 47(6):762-8. PubMed ID: 19402791
    [Abstract] [Full Text] [Related]

  • 4. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
    Semenov AG, Feygina EE.
    Adv Clin Chem; 2018 Jan; 85():1-30. PubMed ID: 29655458
    [Abstract] [Full Text] [Related]

  • 5. Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure.
    Nishikimi T, Okamoto H, Nakamura M, Ogawa N, Horii K, Nagata K, Nakagawa Y, Kinoshita H, Yamada C, Nakao K, Minami T, Kuwabara Y, Kuwahara K, Masuda I, Kangawa K, Minamino N, Nakao K.
    PLoS One; 2013 Jan; 8(1):e53233. PubMed ID: 23365636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
    Semenov AG, Katrukha AG.
    Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.
    Clerico A, Fontana M, Zyw L, Passino C, Emdin M.
    Clin Chem; 2007 May; 53(5):813-22. PubMed ID: 17384013
    [Abstract] [Full Text] [Related]

  • 10. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.
    Luckenbill KN, Christenson RH, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Tate J, Wu AH, Ler R, Apple FS.
    Clin Chem; 2008 Mar; 54(3):619-21. PubMed ID: 18310156
    [No Abstract] [Full Text] [Related]

  • 11. State of the art of immunoassay methods for B-type natriuretic peptides: An update.
    Clerico A, Franzini M, Masotti S, Prontera C, Passino C.
    Crit Rev Clin Lab Sci; 2015 Mar; 52(2):56-69. PubMed ID: 25547534
    [Abstract] [Full Text] [Related]

  • 12. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 13. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A.
    Clin Chem Lab Med; 2004 Jan 20; 42(1):37-44. PubMed ID: 15061378
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials.
    Franzini M, Masotti S, Prontera C, Ripoli A, Passino C, Giovannini S, Zucchelli G, Clerico A.
    Clin Chim Acta; 2013 Sep 23; 424():287-91. PubMed ID: 23850775
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
    Halfinger B, Hammerer-Lercher A, Amplatz B, Sarg B, Kremser L, Lindner HH.
    Clin Chem; 2017 Jan 23; 63(1):359-368. PubMed ID: 28062629
    [Abstract] [Full Text] [Related]

  • 18. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J.
    Clin Chem Lab Med; 2008 Jan 23; 46(11):1507-14. PubMed ID: 18842106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population.
    Alehagen U, Lindstedt G, Levin LA, Dahlström U.
    Int J Cardiol; 2005 Apr 08; 100(1):125-33. PubMed ID: 15820295
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.